Ticker
KAPA
Analysis
Kairos Pharma, Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to KAPA.
Kairos Pharma, Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to KAPA.
KAPA
Stock
$9.2M
Health Technology
Pharmaceuticals: Major
USD
Kairos Pharma, Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to
Kairos Pharma, Ltd. to Present at the LD Micro Invitational
LOS ANGELES, May 08, 2026--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that its An...
LOS ANGELES, April 15, 2026--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that it ha...
LOS ANGELES, March 02, 2026--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces tha...
Review valuation context for Kairos Pharma, Ltd..
Review future growth context for Kairos Pharma, Ltd..
Review past performance context for Kairos Pharma, Ltd..
Review financial health context for Kairos Pharma, Ltd..
Review dividend context for Kairos Pharma, Ltd..
Review management context for Kairos Pharma, Ltd..
Review ownership context for Kairos Pharma, Ltd..
Review other information context for Kairos Pharma, Ltd..
Review community context for Kairos Pharma, Ltd..